CN107668458A - A kind of solid beverage for improving menalgia - Google Patents
A kind of solid beverage for improving menalgia Download PDFInfo
- Publication number
- CN107668458A CN107668458A CN201710847044.1A CN201710847044A CN107668458A CN 107668458 A CN107668458 A CN 107668458A CN 201710847044 A CN201710847044 A CN 201710847044A CN 107668458 A CN107668458 A CN 107668458A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- extract
- menalgia
- raw material
- seed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 12
- 239000007787 solid Substances 0.000 title claims abstract description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 21
- 241000345998 Calamus manan Species 0.000 claims abstract description 20
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 20
- 235000012950 rattan cane Nutrition 0.000 claims abstract description 20
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 18
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 18
- 240000006240 Linum usitatissimum Species 0.000 claims abstract description 17
- 235000004431 Linum usitatissimum Nutrition 0.000 claims abstract description 17
- 235000004426 flaxseed Nutrition 0.000 claims abstract description 17
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 150000002515 isoflavone derivatives Chemical class 0.000 claims abstract description 14
- 235000008696 isoflavones Nutrition 0.000 claims abstract description 14
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 239000006041 probiotic Substances 0.000 claims abstract description 8
- 235000018291 probiotics Nutrition 0.000 claims abstract description 8
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 5
- 235000020748 rosemary extract Nutrition 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 23
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 16
- 239000011726 vitamin B6 Substances 0.000 claims description 12
- 239000011691 vitamin B1 Substances 0.000 claims description 9
- 239000011716 vitamin B2 Substances 0.000 claims description 9
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 8
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 8
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 8
- 239000005913 Maltodextrin Substances 0.000 claims description 8
- 229920002774 Maltodextrin Polymers 0.000 claims description 8
- 229920001100 Polydextrose Polymers 0.000 claims description 8
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 8
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 8
- 229940035034 maltodextrin Drugs 0.000 claims description 8
- 229940035035 polydextrose Drugs 0.000 claims description 8
- 235000013856 polydextrose Nutrition 0.000 claims description 8
- 239000001259 polydextrose Substances 0.000 claims description 8
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 7
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 7
- 229920001202 Inulin Polymers 0.000 claims description 5
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 5
- 210000000481 breast Anatomy 0.000 claims description 5
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 5
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 5
- 229940029339 inulin Drugs 0.000 claims description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 5
- 108010046377 Whey Proteins Proteins 0.000 claims description 4
- 102000007544 Whey Proteins Human genes 0.000 claims description 4
- 235000021119 whey protein Nutrition 0.000 claims description 4
- 235000005979 Citrus limon Nutrition 0.000 claims description 3
- 244000131522 Citrus pyriformis Species 0.000 claims description 3
- 229940092258 rosemary extract Drugs 0.000 claims description 2
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract description 11
- 239000000262 estrogen Substances 0.000 abstract description 5
- 150000003180 prostaglandins Chemical class 0.000 abstract description 5
- 229940011871 estrogen Drugs 0.000 abstract description 4
- 210000004291 uterus Anatomy 0.000 abstract description 4
- 210000003205 muscle Anatomy 0.000 abstract description 3
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 abstract description 2
- 206010063837 Reperfusion injury Diseases 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 239000011149 active material Substances 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 235000015165 citric acid Nutrition 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- 229910001425 magnesium ion Inorganic materials 0.000 abstract description 2
- 230000000116 mitigating effect Effects 0.000 abstract description 2
- 230000004118 muscle contraction Effects 0.000 abstract description 2
- 230000003387 muscular Effects 0.000 abstract description 2
- 150000003254 radicals Chemical class 0.000 abstract description 2
- 210000002460 smooth muscle Anatomy 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 abstract description 2
- 230000004083 survival effect Effects 0.000 abstract description 2
- 239000011782 vitamin Substances 0.000 abstract description 2
- 229930003231 vitamin Natural products 0.000 abstract description 2
- 235000013343 vitamin Nutrition 0.000 abstract description 2
- 229940088594 vitamin Drugs 0.000 abstract description 2
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000000107 myocyte Anatomy 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 11
- 230000000694 effects Effects 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 230000003821 menstrual periods Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 229940124277 aminobutyric acid Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 108010037462 Cyclooxygenase 2 Proteins 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- 102100031951 Oxytocin-neurophysin 1 Human genes 0.000 description 1
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000012947 ischemia reperfusion injury Diseases 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 239000003340 retarding agent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
Abstract
A kind of solid beverage for improving menalgia, it is to be formed by following components raw material by certain part by weight proportioning:U.S. rattan fruit, the root of kudzu vine, linseed, strange sub- seed, haematococcus pluvialis extract, Rosmarinus officinalis extract, isoflavones, probiotics, prebiotics, citric acid, brown sugar, vitamin.The raw material of use cooperates, and improves dysmenorrhoea situation from many aspects, and it is sensitive to alleviate the uterine smooth muscle caused by estrogen;Improve magnesium ion concentration in myometril cell, reduce stimulation of the myocyte to extraneous active material, reduce uterine leio Muscle tensility, make uterus muscular relaxation so as to reach the purpose for the treatment of dysmenorrhoea, the generation of the Prostaglandin PGF2 alpha and prostaglandin LT4 and free radical that cause body dysmenorrhoea is reduced, ischemical reperfusion injury occurs so as to release uterine leio muscular contraction by mitigating uterus, improves gut flora, the absorption rate of active ingredient is improved, beneficial to the Survival and growth of probiotics in vivo.
Description
Technical field
It is specifically a kind of to improve consolidating for menalgia the present invention relates to a kind of solid beverage with medical health care function
Body beverage, belongs to field of health care food.
Background technology
Dysmenorrhoea refer to women before and after menstruation or menstrual period occur abdominal cramps pain, lower abdomen pendant pain, headache, it is weak,
The malaise symptoms such as dizziness, nausea,vomiting,diarrhea, abdominal distension, pain in waist and lower extremities, influence the situation lived and worked.Most of menalgias
For primary dysmenorrhea, the reason for causing primary dysmenorrhea, is a lot, as estrogen secretion is uneven, prostaglandin or leukotriene synthesis with
Discharge excessive, vasopressing and oxytocin secretion increase etc..Existing treatment means are mainly drug therapy, food therapy.
Drug therapy such as NSAIDs (NSAIDs), cyclooxygenase-2 gene (COX-2) inhibitor, oral short-acting contraceptive, calcium ion lead to
Road retarding agent etc..Though these medicines can effectively alleviate primary dysmenorrhea, slowly effect, side effect are larger, to health very
It is unfavorable.Food therapy is a kind of safer reliable method, most commonly brown sugar jujube ginger tea, but effect is general and species
It is single.The dietary product of improvement menalgia also preferable without a kind of effect and instant in the market.
The content of the invention
The purpose of the present invention is for the menalgia problem that becomes increasingly conspicuous, overcomes at present that treatment medicine is single, side effect
Greatly, the defects of ineffective, a kind of solid beverage for improving menalgia is disclosed.
The present invention is formed by following components and raw material proportioning:
U.S. rattan fruit 1-20, root of kudzu vine 2-100, linseed 1-20, strange sub- seed 1-20, haematococcus pluvialis extract 0.2-1.0, fan
Repeatedly fragrant extract 1-10, isoflavones 0.2-0.8, probiotics 0.004-1, prebiotics 0.05-5, citric acid 0.01-0.2,
Brown sugar 0.1-20, vitamin B10.0005-0.0015, vitamin B20.0005-0.0015, vitamin B60.0005-0.0015。
The probiotics is lactobacillus acidophilus, bifidobacterium lactis, Lactobacillus paracasei, the one or more of Lactobacillus plantarum
Compounding.
The prebiotics is inulin, concentrated whey protein powder, galactooligosaccharide, maltodextrin, one kind of polydextrose or
A variety of compoundings.
The preparation method of the present invention is as follows:
U.S. rattan fruit is heat-treated 15-30min by a under 115-121 DEG C of environment, cooling;
B crushes heat treated U.S. rattan fruit, the root of kudzu vine, linseed, strange sub- seed respectively, crosses 80 mesh sieves, be made U.S. rattan fruit powder,
Kudzu-vine root powder, linseed meal, strange sub- seed powder;
C is by weight by U.S. rattan fruit powder, kudzu-vine root powder, linseed meal, strange sub- seed powder, haematococcus pluvialis extract, rosemary
Extract, isoflavones, probiotics, prebiotics, citric acid, brown sugar, vitamin B1, vitamin B2, vitamin B6It is mixed with drying
Conjunction machine is well mixed, and removes unnecessary moisture, then is crushed through pulverizer and homogeneous, it is then cold put, sterilize, be filling, sealing, with every
Wrap 15-25g packing.
Instructions of taking:1-2 times daily, each 15-25g adds 120-180ml warm waters (40-50 DEG C), and stirring is to dissolving, i.e.,
It is drinkable.
The raw material that the present invention uses cooperates, and improves dysmenorrhoea situation from many aspects.Isoflavones is both estrogen
Activator, it is its antagonist again, abundant isoflavones, including daidzein, daidzin, Puerarin and soybean is also contained in the root of kudzu vine
Aglycon -4,7- diglucosides etc..Isoflavones, the root of kudzu vine and vitamin B6It is combined, high dose isoflavones antagonising oestrogen,
It is sensitive to alleviate the uterine smooth muscle caused by estrogen;Vitamin B6Magnesium ion concentration in myometril cell can be improved, reduces flesh
Stimulation of the cell to extraneous active material, vitamin B6The synthesis of aminobutyric acid is also participated in as coenzyme, aminobutyric acid is maincenter
Nerve suppress mediator, content increase can cause it is of flaccid muscles, reduce uterine leio Muscle tensility, uterus muscular relaxation is controlled so as to reach
Treat the purpose of dysmenorrhoea.There are synergy, vitamin B between the vitamin of B races1、B2、B6Equivalent proportioning effect is more preferable.Rosemary carries
It is natural to take thing, and haematococcus pluvialis are containing abundant antioxidant astaxanthin, with containing abundant polyunsaturated fat
The U.S. rattan fruit of acid, linseed, strange sub- seed are engaged, and can reduce the Prostaglandin PGF2 alpha and prostaglandin LT4 for causing body dysmenorrhoea
And the generation of free radical.In addition, by mitigating uterus ischemia reperfusion injury can also occur for alpha-linolenic acid so as to release son
Palace muscle contraction.Lactobacillus acidophilus, bifidobacterium lactis, Lactobacillus paracasei, Lactobacillus plantarum cooperate, and improve enterobacteriaceae
Group, improve the absorption rate of active ingredient.Inulin, concentrated whey protein powder, galactooligosaccharide, maltodextrin, polydextrose
It is matched with probiotics, beneficial to the Survival and growth of probiotics in vivo.
Embodiment
Two embodiments presented below are addressed further under instant component preferred weight part proportioning.
Embodiment one:
The solid beverage of the present invention, formed by following components and raw material proportioning:
U.S. rattan fruit 4, the root of kudzu vine 50, linseed 6, strange sub- seed 4, haematococcus pluvialis extract 0.5, Rosmarinus officinalis extract 2, soybean
Isoflavones 0.4, lactobacillus acidophilus 0.08, bifidobacterium lactis 0.1, Lactobacillus plantarum 0.1, maltodextrin 2, polydextrose 2, lemon
Acid 0.05, brown sugar 5, vitamin B10.0007, vitamin B20.0007, vitamin B60.0007。
The preparation method of the present invention is as follows:
U.S. rattan fruit is heat-treated 20min by a under 121 DEG C of environment, cooling;
B crushes heat treated U.S. rattan fruit, the root of kudzu vine, linseed, strange sub- seed respectively, crosses 80 mesh sieves, be made U.S. rattan fruit powder,
Kudzu-vine root powder, linseed meal, strange sub- seed powder;
C changes kudzu-vine root powder, U.S. rattan fruit powder, linseed meal, strange sub- seed powder, haematococcus pluvialis extract, fan by mass fraction
Fragrant extract, isoflavones, lactobacillus acidophilus, bifidobacterium lactis, Lactobacillus plantarum, maltodextrin, polydextrose, lemon
Acid, brown sugar, vitamin B1, vitamin B2, vitamin B6It is well mixed with dry mixed machine, removes unnecessary moisture, then through crushing
Machine crushes and homogeneous, then cold to put, sterilize, be filling, sealing, and is dispensed with every bag 15g.
Instructions of taking:1-2 times daily, each 15g adds 120ml warm waters (40-50 DEG C), stirring to dissolving, you can drink.
Embodiment two:
The solid beverage of the present invention, formed by following components and raw material proportioning:
U.S. rattan fruit 3, the root of kudzu vine 80, linseed 3, strange sub- seed 6, haematococcus pluvialis extract 0.4, Rosmarinus officinalis extract 4, soybean
Isoflavones 0.3, lactobacillus acidophilus 0.03, bifidobacterium lactis 0.05, Lactobacillus paracasei 0.05, Lactobacillus plantarum 0.1, inulin
1.0, concentrated whey protein powder 0.5, galactooligosaccharide 1.0, maltodextrin 1.0, polydextrose 0.5, citric acid 0.06, brown sugar 9,
Vitamin B10.0009, vitamin B20.0009, vitamin B60.0009。
The preparation method of the present invention is as follows:
U.S. rattan fruit is heat-treated 30min by a under 115 DEG C of environment, cooling;
B crushes the root of kudzu vine, heat treated U.S. rattan fruit, linseed, strange sub- seed respectively, crosses 80 mesh sieves.Be made U.S. rattan fruit powder,
Kudzu-vine root powder, linseed meal, strange sub- seed powder;
C changes kudzu-vine root powder, U.S. rattan fruit powder, linseed meal, strange sub- seed powder, haematococcus pluvialis extract, fan by mass fraction
Fragrant extract, isoflavones, lactobacillus acidophilus, bifidobacterium lactis, Lactobacillus paracasei, Lactobacillus plantarum, inulin, concentrated milk
Albumin powder, galactooligosaccharide, maltodextrin, polydextrose, citric acid, brown sugar, vitamin B1, vitamin B2, vitamin B6With
Dry mixed machine is well mixed, and removes unnecessary moisture, then through pulverizer crushing and homogeneous, it is then cold to put, sterilize, be filling, be close
Envelope, dispensed with every bag 20g.
Instructions of taking:1-2 times daily, each 20g adds 150ml warm waters (40-50 DEG C), stirring to dissolving, you can drink.
Solid beverage of the present invention is in the hospital clinical observation treatment of Guangzhou Agricultural University Of South China, the female of 34 primary dysmenorrheas
Property, there is obvious improvement, now only choosing is following several after taking:
Yuan * *, female is 21 years old, unmarried, and slight lower abdomen spasmic pain occurs in menstrual period, and with cold limbs, head
The symptoms such as pain, continuously take 2 months, 1 time a day, spasmic pain is obviously improved, and is not recurred.
5 * *, female is 26 years old, married, and the symptoms such as waist is ached or sour swollen, swollen breasts, shape are cold occur in menstrual period, in two
Individual menstruation cycle respectively takes 7 days, and 2 times a day, waist, which is ached, or acid is swollen is obviously improved, and does not recur.
What *, female is 20 years old, unmarried, and the symptoms such as swollen breasts, shape be cold occur in menstrual period, and 7 are respectively taken in three menstruation cycles
My god, 1 time a day, swollen breasts, shape are cold to be obviously improved.
Xu * *, female is 35 years old, married, and lower abdomen spasmic pain occurs in menstrual period, and waist is ached or sour swollen, spargosis
Pain and with cold limbs, the symptom such as headache, continuously takes 1 month, 2 times a day, spasmic pain, waist ache or acid it is swollen,
Swollen breasts are obviously improved, and are not recurred.
Xu * *, female is 42 years old, married, and menstrual period occurs serious lower abdomen spasmic pain, waist ache or acid it is swollen, four
The symptoms such as limb is ice-cold, headache, respectively take 7 days, daily 3 times in three menstruation cycles, and spasmic pain, waist are ached or sour swollen, head
Pain is obviously improved, and is not recurred.
Claims (3)
- A kind of 1. solid beverage for improving menalgia, it is characterised in that be by following components and raw material proportioning and Into:U.S. rattan fruit 1-20, root of kudzu vine 2-100, linseed 1-20, strange sub- seed 1-20, haematococcus pluvialis extract 0.2-1.0, rosemary Extract 1-10, isoflavones 0.2-0.8, probiotics 0.004-1, prebiotics 0.05-5, citric acid 0.01-0.2, brown sugar 0.1-20, vitamin B10.0005-0.0015, vitamin B20.0005-0.0015, vitamin B60.0005-0.0015。
- 2. a kind of solid beverage for improving menalgia according to claim 1, it is characterised in that be by following components And raw material proportioning forms:U.S. rattan fruit 4, the root of kudzu vine 50, linseed 6, strange sub- seed 4, haematococcus pluvialis extract 0.5, fan changes Fragrant extract 2, isoflavones 0.4, lactobacillus acidophilus 0.08, bifidobacterium lactis 0.1, Lactobacillus plantarum 0.1, maltodextrin 2, Polydextrose 2, citric acid 0.05, brown sugar 5, vitamin B10.0007, vitamin B20.0007, vitamin B60.0007。
- 3. a kind of solid beverage for improving menalgia according to claim 1, it is characterised in that be by following components And raw material proportioning forms:U.S. rattan fruit 3, the root of kudzu vine 80, linseed 3, strange sub- seed 6, haematococcus pluvialis extract 0.4, fan changes Fragrant extract 4, isoflavones 0.3, lactobacillus acidophilus 0.03, bifidobacterium lactis 0.05, Lactobacillus paracasei 0.05, plant breast Bacillus 0.1, inulin 1.0, concentrated whey protein powder 0.5, galactooligosaccharide 1.0, maltodextrin 1.0, polydextrose 0.5, lemon Acid 0.06, brown sugar 9, vitamin B10.0009, vitamin B20.0009, vitamin B60.0009。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710847044.1A CN107668458A (en) | 2017-09-19 | 2017-09-19 | A kind of solid beverage for improving menalgia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710847044.1A CN107668458A (en) | 2017-09-19 | 2017-09-19 | A kind of solid beverage for improving menalgia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107668458A true CN107668458A (en) | 2018-02-09 |
Family
ID=61136437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710847044.1A Pending CN107668458A (en) | 2017-09-19 | 2017-09-19 | A kind of solid beverage for improving menalgia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107668458A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020132411A1 (en) * | 2018-12-21 | 2020-06-25 | Kimberly-Clark Worldwide, Inc. | Compositions and methods for preventing or treating incontinence, overactive bladder, or menstrual cramping |
CN111714524A (en) * | 2020-05-08 | 2020-09-29 | 南方医科大学南方医院 | Application of lactobacillus murinus in preparation of composition for preventing and treating intestinal ischemia reperfusion injury |
RU2808470C2 (en) * | 2018-12-21 | 2023-11-28 | Кимберли-Кларк Ворлдвайд, Инк. | Compositions and methods of preventing or treating urinary incontinence, bladder overactivity or menstrual cramps |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1273119A (en) * | 1999-05-11 | 2000-11-15 | 吴桂荣 | Composite safflower oil preparation and medicine containing it |
CN101283804A (en) * | 2007-04-09 | 2008-10-15 | 宁小静 | Health-care food |
CN104187680A (en) * | 2014-09-12 | 2014-12-10 | 林元藻 | Preparation method of health food used for enriching blood and regulating menstruation as well as removing freckles and beautifying for woman |
CN104855972A (en) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-full-nutrient formula food for menopause delaying and regulation of females |
CN105454966A (en) * | 2015-12-11 | 2016-04-06 | 苏州泽达兴邦医药科技有限公司 | Probiotics solid beverage for improving gastrointestinal tract and immunity and preparation method thereof |
CN106798755A (en) * | 2017-03-10 | 2017-06-06 | 泰安大凡神农制药有限公司 | A kind of probiotic composition and its application with conditioning breast hyperplasia function |
-
2017
- 2017-09-19 CN CN201710847044.1A patent/CN107668458A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1273119A (en) * | 1999-05-11 | 2000-11-15 | 吴桂荣 | Composite safflower oil preparation and medicine containing it |
CN101283804A (en) * | 2007-04-09 | 2008-10-15 | 宁小静 | Health-care food |
CN104187680A (en) * | 2014-09-12 | 2014-12-10 | 林元藻 | Preparation method of health food used for enriching blood and regulating menstruation as well as removing freckles and beautifying for woman |
CN104855972A (en) * | 2015-04-22 | 2015-08-26 | 劲膳美生物科技股份有限公司 | Non-full-nutrient formula food for menopause delaying and regulation of females |
CN105454966A (en) * | 2015-12-11 | 2016-04-06 | 苏州泽达兴邦医药科技有限公司 | Probiotics solid beverage for improving gastrointestinal tract and immunity and preparation method thereof |
CN106798755A (en) * | 2017-03-10 | 2017-06-06 | 泰安大凡神农制药有限公司 | A kind of probiotic composition and its application with conditioning breast hyperplasia function |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020132411A1 (en) * | 2018-12-21 | 2020-06-25 | Kimberly-Clark Worldwide, Inc. | Compositions and methods for preventing or treating incontinence, overactive bladder, or menstrual cramping |
CN113164534A (en) * | 2018-12-21 | 2021-07-23 | 金伯利-克拉克环球有限公司 | Compositions and methods for preventing or treating incontinence, overactive bladder, or menstrual cramps |
GB2595089A (en) * | 2018-12-21 | 2021-11-17 | Reid Gregor | Compositions and methods for preventing or treating incontinence, overactive bladder, or menstrual cramping |
GB2595089B (en) * | 2018-12-21 | 2023-02-15 | Reid Gregor | Compositions for use in methods for preventing or treating incontinence, overactive bladder, or menstrual cramping |
RU2808470C2 (en) * | 2018-12-21 | 2023-11-28 | Кимберли-Кларк Ворлдвайд, Инк. | Compositions and methods of preventing or treating urinary incontinence, bladder overactivity or menstrual cramps |
CN111714524A (en) * | 2020-05-08 | 2020-09-29 | 南方医科大学南方医院 | Application of lactobacillus murinus in preparation of composition for preventing and treating intestinal ischemia reperfusion injury |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102940155B (en) | Duckling feed for cherry valley duck and preparation method thereof | |
CN106955335B (en) | Traditional Chinese medicine microecological preparation for preventing calf diarrhea and preparation method thereof | |
CN104304790A (en) | Feed for lactating sows | |
CN109430407A (en) | Probiotic combinations preparation | |
CN104939208A (en) | Madder soup seasoning for cooling blood and activating blood and production method of madder soup seasoning | |
WO2011091623A1 (en) | Functional nutriment with effects of promoting lactation and recovery for postpartum women and its preparation methods | |
CN103110861A (en) | Granular preparation for preventing infants from getting inflamed and adjusting intestines and stomach and preparation method thereof | |
CN111771971A (en) | Composition beneficial to regulating intestinal tract, promoting digestion and improving constipation and preparation method thereof | |
CN104397367A (en) | Chicken fattening feed | |
CN104256096A (en) | Feed additive and feed for treating piglet diarrhea | |
CN105379973A (en) | Goat feed | |
CN111955720A (en) | Special postpartum lactation-promoting diet for puerpera and preparation method thereof | |
CN108338258A (en) | A kind of farrowing sow Synbiotic feed additive and preparation method and application | |
CN108936628A (en) | A kind of specific full nutritional formulas and preparation method thereof that patients with cerebral apoplexy is edible | |
CN107334156A (en) | Lactagogue full nutrition formula food | |
CN105685868A (en) | Probiotics compound cranberry female reproduction health nutrition supplementary | |
KR20170072003A (en) | Method of manufacturing a fermented food that can help diabetes using the Hordeum vulgare L. and fermented food that has been produced by it | |
CN107668458A (en) | A kind of solid beverage for improving menalgia | |
CN104207148A (en) | Cervical cancer full nutrient formula food | |
CN103535468A (en) | Formula and production method of pine nut bowel relaxing tea | |
CN104146241B (en) | A kind of help defaecation health composition and preparation method | |
CN102511876A (en) | Hawthorn red jujube thick syrup | |
CN106472684A (en) | A kind of milk product | |
CN104547770A (en) | Fermented traditional Chinese medicament for promoting growth of livestock and poultry and preparation method for fermented traditional Chinese medicament | |
CN104304809A (en) | Feed additive for cow during lactation period and application of feed additive |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180209 |